Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
4/24/2024
Review of Leading Class 1 New Drugs by Chinese Sales Value in 2023
4/24/2024
NHC Issues Announcement on Jurisdiction of Human Genetic Resource Mana...
4/23/2024
Novartis Actively Evaluating Ties with Chinese Contractors Amidst US B...
4/23/2024
NMPA Issues Announcement on Further Strengthening the Drug Distributio...
4/23/2024
NMPA Issues the Announcement on Relevant Matters Concerning the Optimi...
4/19/2024
Drug R&D and Product Registration News Digest April 2024 (3)
4/19/2024
Recent Executive Moves
4/18/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (81...
4/18/2024
CDE Issues the Detailed Rules on Adding Pediatric Information to the P...
4/18/2024
Andao Pharma/Kind Pharma and Fibrogen Settle on IP Dispute over HIF- P...
4/17/2024
China Announces the 2024 Special Rectification Plan for Illegal Activi...
More>>
Feature Articles
4/23/2024
Free Pricing in China for Highly Innovative Medicines (LinkedIn)
4/19/2024
How BIO CEO's Cozy Relationship with WuXi Soured (STAT)
4/19/2024
China's Drugmakers Can't Sell mRNA Shots But Haven't Quit Yet (Reuters...
4/17/2024
A Risky Bet: Zai Lab's Uncertain Future (Seeking Alpha)
4/16/2024
America Hits Chinese Biotech — And Its Own Drugmakers (Economist)
4/15/2024
The Pharmaceutical Playbook for Asia’s Private Market (PharmExec)
4/15/2024
China Biopharma Tracker – Q1 2024 (PharmaDJ)
4/11/2024
Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...
4/11/2024
Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...
4/10/2024
Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...
4/9/2024
CEO Podcast: Hengrui's US Subsidiary's CEO, CMO On Chinese Pharma Goin...
More>>
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit